| Literature DB >> 21731554 |
Ana Catarina Guedes1, Helena M Amaro1, Francisco Xavier Malcata2,3.
Abstract
Marine microalgae constitute a natural source of a variety of drugs for pharmaceutical, food and cosmetic applications-which encompass carotenoids, among others. A growing body of experimental evidence has confirmed that these compounds can play important roles in prevention (and even treatment) of human diseases and health conditions, e.g., cancer, cardiovascular problems, atherosclerosis, rheumatoid arthritis, muscular dystrophy, cataracts and some neurological disorders. The underlying features that may account for such favorable biological activities are their intrinsic antioxidant, anti-inflammatory and antitumoral features. In this invited review, the most important issues regarding synthesis of carotenoids by microalgae are described and discussed-from both physiological and processing points of view. Current gaps of knowledge, as well as technological opportunities in the near future relating to this growing field of interest, are also put forward in a critical manner.Entities:
Keywords: astaxanthin; bioproduction; extraction; lutein; β-carotene
Mesh:
Substances:
Year: 2011 PMID: 21731554 PMCID: PMC3124977 DOI: 10.3390/md9040625
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 6.085
Carotenoids produced by selected microalgae.
| β-carotene | [ | |
| Astaxanthin, cantaxanthin, lutein | [ | |
| Cantaxanthin, astaxanthin | [ | |
| Canthaxanthin, astaxanthin, β-carotene | [ | |
| Lutein, β-carotene | [ |
Optimal conditions of production of carotenoids by selected microalgae.
| Semi-continuous outdoor, closed tubular (55 L) | Biomass: 2 g m–2 d–1 | [ | |||
| Continuous turbidostat, flat-panel (2.5 L) | β-Carotene: 13.5 mg L–1 d–1 | [ | |||
| Continuous turbidostat, flat-panel (1.9 L) with | β-Carotene: 0.7 mg L–1 d–1 | ||||
| Batch (0.2 L, 4–7 d) | Lutein content: 5.5 mg g–1 L–1 d–1 | [ | |||
| Continuous outdoor, tubular (55 L) | Biomass: 7.2 mg L–1 d–1 | [ | |||
| - | Semicontinuous outdoor, open tank (100 L) | Biomass: 100 mg m–2 d–1 | [ | ||
| Continuous (2 L) | Lutein: 4.9 mg L–1 d–1 | [ | |||
| Continuous outdoor, tubular | Lutein: 5.31 mg m–2 d –1 | [ | |||
| Batch (16 L) | Lutein: 10 mg L–1 d–1 | [ | |||
| Batch (0.2 L) | Lutein: 3.4 mg L–1 d–1 | [ | |||
| Lutein: 1.05 mg L–1 h–1 | |||||
| Lutein: 0.70 mg L–1 h–1 | |||||
| Batch (250 mL) | Astaxanthin:10.3 mg L−1 | [ | |||
| Continuous chemostat, tubular (50 L) | Biomass: 0.7 g L−1d−1 | [ | |||
| Batch (1 L) | Astaxanthin content: 98 mg g−1biomass | [ | |||
| Enclosed outdoor (25,000 L) | Biomass: 90 g m−2 | [ |
AF: air flow; LDC: light/dark cycle; LI: light irradiance; MM: metabolic mode; SR: stirring rate; T: temperature.
SFE yields of total carotenoids (including lutein), and of lutein specifically, by selected microalgae.
| 200 bar/40 °C/180 min | 0.152 | - | 0.524 | [ | |
| 200 bar/50 °C/180 min | 0.152 | - | 0.410 | ||
| 200 bar/60 °C/180 min | 0.125 | - | 1.389 | ||
| 300 bar/40 °C/180 min | 0.208 | - | 0.258 | ||
| 300 bar/50 °C/180 min | 0.248 | - | 0.230 | ||
| 300 bar/60 °C/180 min | 0.250 | - | 0.179 | ||
| 200 bar/40 °C/198 min | 0.011 | - | - | [ | |
| 200 bar/55 °C/180 min | 0.008 | - | - | ||
| 350 bar/55 °C/252 min | 0.080 | - | - | ||
| 200 bar/40 °C/180 min | 0.386 | - | 193.000 | [ | |
| 200 bar/50 °C/180 min | 1.225 | - | 23.113 | ||
| 200 bar/60 °C/180 min | 0.405 | - | 101.25 | ||
| 300 bar/40 °C/180 min | 0.748 | - | 32.522 | ||
| 300 bar/50 °C/180 min | 1.511 | - | 19.372 | ||
| 300 bar/60 °C/180 min | 0.808 | - | 46.316 | ||
| 200 bar/32 °C/300 min | - | 0.0013 | - | [ | |
| 200 bar/46 °C/300 min | - | 0.0000 | - | ||
| 200 bar/60 °C/300 min | - | 0.0109 | - | ||
| 300 bar/39 °C/300 min | - | 0.0236 | - | ||
| 300 bar/53 °C/300 min | - | 0.0090 | - |